NYSEAMERICAN:XTNT Xtant Medical Q3 2026 Earnings Date & Estimates $0.30 -0.02 (-4.93%) As of 04:10 PM Eastern Xtant Medical is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeBefore Market OpensConference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Xtant Medical in Q3 2026Xtant Medical is expected to post earnings of -$0.0250 per share on revenue of $25.48 million. In the same quarter a year earlier Xtant Medical reported $0.01 per share on revenue of $27.77 million. Xtant Medical last reported on August 11, 2026, posting -$0.07 per share and missing the -$0.02 consensus estimate. Xtant Medical has beaten the consensus EPS estimate in 2 of its last 6 quarters.Consensus EstimatesConsensus EPS-$0.0250Expected Revenue$25.48 millionPrior-Year EPS$0.01Prior-Year Revenue$27.77 millionExpected EPS Growth-350.0%Expected Revenue Growth-8.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.07 (Missed by -$0.05)Last Quarter Revenue$23.03 millionEPS Beat Rate2 of last 6 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Xtant Medical Q3 2026 Earnings FAQ When does Xtant Medical report Q3 2026 earnings? Xtant Medical (NYSEAMERICAN:XTNT) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Xtant Medical's Q3 2026 earnings call? Xtant Medical's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Xtant Medical? Analysts expect Xtant Medical to post earnings of -$0.0250 per share for Q3 2026. How much revenue is Xtant Medical expected to report? The consensus revenue estimate for Xtant Medical is $25.48 million for Q3 2026. Xtant Medical Earnings HeadlinesLucid Capital Markets initiates coverage of Xtant Medical Holdings (XTNT) with buy recommendationSeptember 3, 2026 | msn.comXtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental MarketAugust 27, 2026 | prnewswire.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 15 at 1:00 AM | Chaikin Analytics (Ad)Xtant Medical (XTNT) Stock Forecast & Price TargetAugust 26, 2026 | investing.comXtant Medical Holdings (XTNT) Receives a Rating Update from a Top AnalystAugust 14, 2026 | theglobeandmail.comXtant Medical (XTNT) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comSee More Xtant Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Xtant Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xtant Medical and other key companies, straight to your email. Email Address About Xtant MedicalXtant Medical (NYSEAMERICAN:XTNT) is a medical technology company focused on developing, manufacturing and distributing products used in orthopedic and spinal procedures. Its portfolio is designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal structures. The company offers a range of biologic products, including human tissue allografts, demineralized bone matrix and other bone-graft substitutes. It also provides implantable devices and surgical instruments for spine and orthopedic applications, including products used in interbody fusion and spinal fixation procedures. Xtant Medical is headquartered in Belgrade, Montana, and serves the U.S. orthopedic and spine markets through direct sales and distribution relationships. The company was formerly known as Bacterin International Holdings and adopted the Xtant Medical name in 2015. Its products are used primarily by surgeons, hospitals and other healthcare providers.View Xtant Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
